UnitedHealth Group (NYSE:UNH) Updates FY 2026 Earnings Guidance

UnitedHealth Group (NYSE:UNH) issued an update on its FY 2026 earnings guidance on Thursday morning. The company provided earnings per share (EPS) guidance of 19.500-20.000 for the period, compared to the consensus estimate of 18.370. The company issued revenue guidance of -, compared to the consensus revenue estimate of $444.2 billion.

UnitedHealth Group Price Performance

UNH stock opened at $417.33 on Thursday. The company’s 50-day moving average price is $402.80 and its two-hundred day moving average price is $341.04. The firm has a market cap of $378.99 billion, a P/E ratio of 31.52, a P/E/G ratio of 1.70 and a beta of 0.62. UnitedHealth Group has a 12 month low of $234.60 and a 12 month high of $434.30. The company has a quick ratio of 0.80, a current ratio of 0.80 and a debt-to-equity ratio of 0.69.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, April 21st. The healthcare conglomerate reported $7.23 EPS for the quarter, topping analysts’ consensus estimates of $6.76 by $0.47. The company had revenue of $111.65 billion for the quarter, compared to analyst estimates of $109.84 billion. UnitedHealth Group had a net margin of 2.68% and a return on equity of 14.65%. UnitedHealth Group’s revenue was up 2.0% compared to the same quarter last year. During the same quarter in the previous year, the business earned $7.20 earnings per share. UnitedHealth Group has set its FY 2026 guidance at 18.250- EPS. On average, analysts anticipate that UnitedHealth Group will post 18.39 earnings per share for the current fiscal year.

UnitedHealth Group Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, June 23rd. Investors of record on Monday, June 15th were given a $2.32 dividend. This represents a $9.28 dividend on an annualized basis and a yield of 2.2%. The ex-dividend date of this dividend was Monday, June 15th. This is a positive change from UnitedHealth Group’s previous quarterly dividend of $2.21. UnitedHealth Group’s dividend payout ratio is presently 70.09%.

Wall Street Analysts Forecast Growth

Several research analysts have issued reports on UNH shares. Morgan Stanley increased their price target on UnitedHealth Group from $453.00 to $468.00 and gave the stock an “overweight” rating in a report on Tuesday, June 30th. Sanford C. Bernstein restated an “outperform” rating on shares of UnitedHealth Group in a research note on Tuesday, June 23rd. Leerink Partners lifted their price target on UnitedHealth Group from $400.00 to $462.00 and gave the stock an “outperform” rating in a report on Wednesday, June 17th. HSBC upped their price objective on UnitedHealth Group from $300.00 to $380.00 and gave the company a “hold” rating in a research note on Monday, July 6th. Finally, Weiss Ratings raised shares of UnitedHealth Group from a “hold (c-)” rating to a “hold (c)” rating in a report on Friday, July 10th. Two analysts have rated the stock with a Strong Buy rating, twenty have issued a Buy rating, four have issued a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $429.50.

Insiders Place Their Bets

In other UnitedHealth Group news, CEO Patrick Hugh Conway sold 800 shares of the firm’s stock in a transaction on Thursday, April 23rd. The stock was sold at an average price of $355.00, for a total transaction of $284,000.00. Following the completion of the transaction, the chief executive officer owned 17,805 shares of the company’s stock, valued at approximately $6,320,775. This trade represents a 4.30% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. 0.28% of the stock is currently owned by insiders.

UnitedHealth Group News Summary

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: UnitedHealth reported Q2 adjusted EPS of $6.38 on revenue of $112.03 billion, both above analyst estimates, signaling better-than-expected operating performance. UnitedHealth Group Reports Second Quarter 2026 Results
• Positive Sentiment: The company lifted FY 2026 EPS guidance to $19.50-$20.00, well above prior expectations and the consensus estimate, suggesting stronger earnings momentum ahead. UnitedHealth blows past estimates, hikes earnings outlook as it reins in costs
• Positive Sentiment: Medical costs continued to ease, helping boost net income to $5.48 billion and improving the outlook for margins and free cash flow. UnitedHealth raises 2026 forecast as it controls medical costs
• Positive Sentiment: Analysts responded positively ahead of and after earnings, with multiple price-target hikes and an upgrade from Zacks Research, reinforcing bullish sentiment around the stock. Analyst price target and rating updates
• Neutral Sentiment: Investors are also watching UNH’s AI investment and operational simplification efforts, which could support future efficiency gains, but the impact is still longer term. UnitedHealth Is Investing $1.5 Billion in AI and Targeting a 2-to-1 Return. Here Is What That Means for the Bull Case.

Institutional Trading of UnitedHealth Group

Institutional investors have recently bought and sold shares of the company. Revolve Wealth Partners LLC lifted its position in UnitedHealth Group by 137.1% in the 4th quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate’s stock valued at $2,033,000 after acquiring an additional 2,324 shares in the last quarter. Brighton Jones LLC raised its position in UnitedHealth Group by 176.2% in the 4th quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate’s stock worth $22,384,000 after purchasing an additional 28,231 shares during the period. Strive Financial Group LLC purchased a new stake in UnitedHealth Group during the fourth quarter worth $65,000. Garton & Associates Financial Advisors LLC purchased a new stake in shares of UnitedHealth Group during the 4th quarter worth $112,000. Finally, Prosperity Bancshares Inc bought a new position in UnitedHealth Group in the fourth quarter worth about $114,000. 87.86% of the stock is owned by hedge funds and other institutional investors.

About UnitedHealth Group

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.